APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duck Virus Enteritis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Duck Virus Enteritis Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025197 pages

Choose your research edition.

Industry ResearchDuck Virus Enteritis Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Duck Virus Enteritis Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Duck Virus Enteritis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duck Virus Enteritis Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Duck Virus Enteritis Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Duck Virus Enteritis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Duck Virus Enteritis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Duck Virus Enteritis Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Duck Virus Enteritis Vaccine market include Veterinary Research Institute, Ringpu (Tianjin)Bio-Pharmacy, Chengdu TECBOND Biological, MSD Animal Health (Merck), International Duck Research Cooperative, Institute of Veterinary Preventive Medicine, Institute of Animal Health and Veterinary Biologicals and Ceva Santé Animale, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Duck Virus Enteritis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Duck Virus Enteritis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Duck Virus Enteritis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Duck Virus Enteritis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Duck Virus Enteritis Vaccine Segment by Company

Veterinary Research Institute

Ringpu (Tianjin)Bio-Pharmacy

Chengdu TECBOND Biological

MSD Animal Health (Merck)

International Duck Research Cooperative

Institute of Veterinary Preventive Medicine

Institute of Animal Health and Veterinary Biologicals

Ceva Santé Animale

Duck Virus Enteritis Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Duck Virus Enteritis Vaccine Segment by Application

Duck

Others

Duck Virus Enteritis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Duck Virus Enteritis Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Duck Virus Enteritis Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Duck Virus Enteritis Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Duck Virus Enteritis Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duck Virus Enteritis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duck Virus Enteritis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duck Virus Enteritis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Duck Virus Enteritis Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Duck Virus Enteritis Vaccine industry.

Chapter 3: Detailed analysis of Duck Virus Enteritis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Duck Virus Enteritis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Duck Virus Enteritis Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Duck Virus Enteritis Vaccine Industry Trends Table 2. Duck Virus Enteritis Vaccine Industry Drivers Table 3. Duck Virus Enteritis Vaccine Industry Opportunities and Challenges Table 4. Duck Virus Enteritis Vaccine Industry Restraints Table 5. Global Duck Virus Enteritis Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Duck Virus Enteritis Vaccine Revenue Share by Company (2021-2026) Table 7. Global Duck Virus Enteritis Vaccine Sales Volume by Company (m units) & (2021-2026) Table 8. Global Duck Virus Enteritis Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Duck Virus Enteritis Vaccine Average Price (US$/k unit) of Company (2021-2026) Table 10. Global Duck Virus Enteritis Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Duck Virus Enteritis Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Duck Virus Enteritis Vaccine Company, Product Type & Application Table 13. Global Duck Virus Enteritis Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Duck Virus Enteritis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Killed Vaccines Table 19. Global Duck Virus Enteritis Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (m units) Table 20. Global Duck Virus Enteritis Vaccine Sales Volume by Type (2021-2026) & (m units) Table 21. Global Duck Virus Enteritis Vaccine Sales Volume by Type (2027-2032) & (m units) Table 22. Global Duck Virus Enteritis Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Duck Virus Enteritis Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Duck Virus Enteritis Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Duck Virus Enteritis Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Duck Virus Enteritis Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Duck Virus Enteritis Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Duck Virus Enteritis Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Duck Table 30. Significant Companies of Others Table 31. Global Duck Virus Enteritis Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (m units) Table 32. Global Duck Virus Enteritis Vaccine Sales Volume by Application (2021-2026) & (m units) Table 33. Global Duck Virus Enteritis Vaccine Sales Volume by Application (2027-2032) & (m units) Table 34. Global Duck Virus Enteritis Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Duck Virus Enteritis Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Duck Virus Enteritis Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Duck Virus Enteritis Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Duck Virus Enteritis Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Duck Virus Enteritis Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Duck Virus Enteritis Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Duck Virus Enteritis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 42. Global Duck Virus Enteritis Vaccine Sales by Region (2021-2026) & (m units) Table 43. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Duck Virus Enteritis Vaccine Sales by Region (2027-2032) & (m units) Table 45. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Duck Virus Enteritis Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Duck Virus Enteritis Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Duck Virus Enteritis Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Duck Virus Enteritis Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Duck Virus Enteritis Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Duck Virus Enteritis Vaccine Market Average Price (US$/k unit) by Region (2021-2026) Table 52. Global Duck Virus Enteritis Vaccine Market Average Price (US$/k unit) by Region (2027-2032) Table 53. Global Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (m units) Table 54. Global Duck Virus Enteritis Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Duck Virus Enteritis Vaccine Sales by Country (2021-2026) & (m units) Table 56. Global Duck Virus Enteritis Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Duck Virus Enteritis Vaccine Sales by Country (2027-2032) & (m units) Table 58. Global Duck Virus Enteritis Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Duck Virus Enteritis Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Duck Virus Enteritis Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Duck Virus Enteritis Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Duck Virus Enteritis Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Veterinary Research Institute Company Information Table 64. Veterinary Research Institute Business Overview Table 65. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 66. Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio Table 67. Veterinary Research Institute Recent Development Table 68. Ringpu (Tianjin)Bio-Pharmacy Company Information Table 69. Ringpu (Tianjin)Bio-Pharmacy Business Overview Table 70. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 71. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio Table 72. Ringpu (Tianjin)Bio-Pharmacy Recent Development Table 73. Chengdu TECBOND Biological Company Information Table 74. Chengdu TECBOND Biological Business Overview Table 75. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 76. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio Table 77. Chengdu TECBOND Biological Recent Development Table 78. MSD Animal Health (Merck) Company Information Table 79. MSD Animal Health (Merck) Business Overview Table 80. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 81. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio Table 82. MSD Animal Health (Merck) Recent Development Table 83. International Duck Research Cooperative Company Information Table 84. International Duck Research Cooperative Business Overview Table 85. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 86. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio Table 87. International Duck Research Cooperative Recent Development Table 88. Institute of Veterinary Preventive Medicine Company Information Table 89. Institute of Veterinary Preventive Medicine Business Overview Table 90. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 91. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio Table 92. Institute of Veterinary Preventive Medicine Recent Development Table 93. Institute of Animal Health and Veterinary Biologicals Company Information Table 94. Institute of Animal Health and Veterinary Biologicals Business Overview Table 95. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 96. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio Table 97. Institute of Animal Health and Veterinary Biologicals Recent Development Table 98. Ceva Santé Animale Company Information Table 99. Ceva Santé Animale Business Overview Table 100. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (m units), Value (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 101. Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio Table 102. Ceva Santé Animale Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Duck Virus Enteritis Vaccine Distributors List Table 106. Duck Virus Enteritis Vaccine Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Duck Virus Enteritis Vaccine Product Image Figure 2. Global Duck Virus Enteritis Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duck Virus Enteritis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Duck Virus Enteritis Vaccine Sales (2021-2032) & (m units) Figure 5. Global Duck Virus Enteritis Vaccine Sales Average Price (US$/k unit) & (2021-2032) Figure 6. Global Duck Virus Enteritis Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Killed Vaccines Image Figure 11. Global Duck Virus Enteritis Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (m units) Figure 12. Global Duck Virus Enteritis Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Duck Virus Enteritis Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Duck Virus Enteritis Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Duck Virus Enteritis Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Duck Virus Enteritis Vaccine Sales Value Share by Type (2021-2032) Figure 17. Duck Image Figure 18. Others Image Figure 19. Global Duck Virus Enteritis Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (m units) Figure 20. Global Duck Virus Enteritis Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Duck Virus Enteritis Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Duck Virus Enteritis Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Duck Virus Enteritis Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Duck Virus Enteritis Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Duck Virus Enteritis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 26. Global Duck Virus Enteritis Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Duck Virus Enteritis Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Duck Virus Enteritis Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Duck Virus Enteritis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Duck Virus Enteritis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Duck Virus Enteritis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Duck Virus Enteritis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Duck Virus Enteritis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Duck Virus Enteritis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Duck Virus Enteritis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Duck Virus Enteritis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Duck Virus Enteritis Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Duck Virus Enteritis Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Duck Virus Enteritis Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Duck Virus Enteritis Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Duck
  • Others
Companies covered
  • Veterinary Research Institute
  • Ringpu (Tianjin)Bio-Pharmacy
  • Chengdu TECBOND Biological
  • MSD Animal Health (Merck)
  • International Duck Research Cooperative
  • Institute of Veterinary Preventive Medicine
  • Institute of Animal Health and Veterinary Biologicals
  • Ceva Santé Animale

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Duck Virus Enteritis Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Duck Virus Enteritis Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Duck Virus Enteritis Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Duck Virus Enteritis Vaccine Market Dynamics
  1. 2.1 Duck Virus Enteritis Vaccine Industry Trends
  2. 2.2 Duck Virus Enteritis Vaccine Industry Drivers
  3. 2.3 Duck Virus Enteritis Vaccine Industry Opportunities and Challenges
  4. 2.4 Duck Virus Enteritis Vaccine Industry Restraints
3 Duck Virus Enteritis Vaccine Market by Company
  1. 3.1 Global Duck Virus Enteritis Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Duck Virus Enteritis Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Duck Virus Enteritis Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Duck Virus Enteritis Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Duck Virus Enteritis Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Duck Virus Enteritis Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Duck Virus Enteritis Vaccine Company Product Type and Application
  8. 3.8 Global Duck Virus Enteritis Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Duck Virus Enteritis Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Duck Virus Enteritis Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Duck Virus Enteritis Vaccine Market by Type
  1. 4.1 Duck Virus Enteritis Vaccine Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Duck Virus Enteritis Vaccine Sales Volume by Type
  5. 4.2.1 Global Duck Virus Enteritis Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Duck Virus Enteritis Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Duck Virus Enteritis Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Duck Virus Enteritis Vaccine Sales Value by Type
  9. 4.3.1 Global Duck Virus Enteritis Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Duck Virus Enteritis Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Duck Virus Enteritis Vaccine Sales Value Share by Type (2021-2032)
5 Duck Virus Enteritis Vaccine Market by Application
  1. 5.1 Duck Virus Enteritis Vaccine Application Introduction
  2. 5.1.1 Duck
  3. 5.1.2 Others
  4. 5.2 Global Duck Virus Enteritis Vaccine Sales Volume by Application
  5. 5.2.1 Global Duck Virus Enteritis Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Duck Virus Enteritis Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Duck Virus Enteritis Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Duck Virus Enteritis Vaccine Sales Value by Application
  9. 5.3.1 Global Duck Virus Enteritis Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Duck Virus Enteritis Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Duck Virus Enteritis Vaccine Sales Value Share by Application (2021-2032)
6 Duck Virus Enteritis Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Duck Virus Enteritis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Duck Virus Enteritis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Duck Virus Enteritis Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Duck Virus Enteritis Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Duck Virus Enteritis Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Duck Virus Enteritis Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Duck Virus Enteritis Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Duck Virus Enteritis Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Duck Virus Enteritis Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Duck Virus Enteritis Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Duck Virus Enteritis Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Duck Virus Enteritis Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Duck Virus Enteritis Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Duck Virus Enteritis Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Duck Virus Enteritis Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Duck Virus Enteritis Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Duck Virus Enteritis Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Duck Virus Enteritis Vaccine Sales Value Share by Country, 2025 VS 2032
7 Duck Virus Enteritis Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Duck Virus Enteritis Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Duck Virus Enteritis Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Duck Virus Enteritis Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Duck Virus Enteritis Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Duck Virus Enteritis Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Duck Virus Enteritis Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Duck Virus Enteritis Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Duck Virus Enteritis Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Duck Virus Enteritis Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Duck Virus Enteritis Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Duck Virus Enteritis Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Veterinary Research Institute
  2. 8.1.1 Veterinary Research Institute Company Information
  3. 8.1.2 Veterinary Research Institute Business Overview
  4. 8.1.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Portfolio
  6. 8.1.5 Veterinary Research Institute Recent Developments
  7. 8.2 Ringpu (Tianjin)Bio-Pharmacy
  8. 8.2.1 Ringpu (Tianjin)Bio-Pharmacy Company Information
  9. 8.2.2 Ringpu (Tianjin)Bio-Pharmacy Business Overview
  10. 8.2.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Portfolio
  12. 8.2.5 Ringpu (Tianjin)Bio-Pharmacy Recent Developments
  13. 8.3 Chengdu TECBOND Biological
  14. 8.3.1 Chengdu TECBOND Biological Company Information
  15. 8.3.2 Chengdu TECBOND Biological Business Overview
  16. 8.3.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Portfolio
  18. 8.3.5 Chengdu TECBOND Biological Recent Developments
  19. 8.4 MSD Animal Health (Merck)
  20. 8.4.1 MSD Animal Health (Merck) Company Information
  21. 8.4.2 MSD Animal Health (Merck) Business Overview
  22. 8.4.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Portfolio
  24. 8.4.5 MSD Animal Health (Merck) Recent Developments
  25. 8.5 International Duck Research Cooperative
  26. 8.5.1 International Duck Research Cooperative Company Information
  27. 8.5.2 International Duck Research Cooperative Business Overview
  28. 8.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Portfolio
  30. 8.5.5 International Duck Research Cooperative Recent Developments
  31. 8.6 Institute of Veterinary Preventive Medicine
  32. 8.6.1 Institute of Veterinary Preventive Medicine Company Information
  33. 8.6.2 Institute of Veterinary Preventive Medicine Business Overview
  34. 8.6.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Portfolio
  36. 8.6.5 Institute of Veterinary Preventive Medicine Recent Developments
  37. 8.7 Institute of Animal Health and Veterinary Biologicals
  38. 8.7.1 Institute of Animal Health and Veterinary Biologicals Company Information
  39. 8.7.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  40. 8.7.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Portfolio
  42. 8.7.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  43. 8.8 Ceva Santé Animale
  44. 8.8.1 Ceva Santé Animale Company Information
  45. 8.8.2 Ceva Santé Animale Business Overview
  46. 8.8.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Portfolio
  48. 8.8.5 Ceva Santé Animale Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Duck Virus Enteritis Vaccine Value Chain Analysis
  2. 9.1.1 Duck Virus Enteritis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Duck Virus Enteritis Vaccine Sales Mode & Process
  6. 9.2 Duck Virus Enteritis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Duck Virus Enteritis Vaccine Distributors
  9. 9.2.3 Duck Virus Enteritis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst